In a contemporary breast cancer screening setting with digital breast tomosynthesis and multimodal supplemental screening, approximately half of false-negative cancers were missed, one-quarter were true interval, and one-quarter were mammographically occult cancers.
No takes yet. Share an insight, caveat, or question.
Grimm et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: